Foreign Drug Pricing Policy Creates Unfavorable American Outcomes

The 'Most Favored Nation' ( MFN ) policy would tie Medicaid drug rebates to the lowest prices paid by foreign countries.

Most Medicaid patients already pay less than $8 for their medicines today .

Patients living in countries that have adopted government price controls on pharmaceutical treatments consistently have access to fewer innovative medicines.

Fix the 340B program, which was designed as a safety net but is now exploited by hospitals to mark up drugs and pad profits.

Fixing 340B would make this problem worse by distorting rebate calculations.

We’ve already seen the harmful effects of price control policies in the Inflation Reduction Act .